BAY-091 | Interleukin Related interleukin-related.com

Product Name :
BAY-091

Search keywords :
BAY-091

drugId :
null

Target Vo:
Undisclosed

Target Vo Short Name :
Undisclosed

Moa_Name:
Undisclosed

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bayer AG

Active Company_Name :
Bayer AG

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AKT1 Rabbit mAb Description
alpha smooth muscle ActinRabbit mAb manufacturer
S100A10 Antibody (YA675): S100A10 Antibody (YA675) is a non-conjugated and Mouse origined monoclonal antibody about 11 kDa, targeting to S100A10 (6F4). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts